1. Home
  2. EVOK vs OMH Comparison

EVOK vs OMH Comparison

Compare EVOK & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • OMH
  • Stock Information
  • Founded
  • EVOK 2007
  • OMH 2015
  • Country
  • EVOK United States
  • OMH Singapore
  • Employees
  • EVOK N/A
  • OMH N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • OMH Real Estate
  • Sector
  • EVOK Health Care
  • OMH Finance
  • Exchange
  • EVOK Nasdaq
  • OMH Nasdaq
  • Market Cap
  • EVOK 4.2M
  • OMH 13.6M
  • IPO Year
  • EVOK 2013
  • OMH 2023
  • Fundamental
  • Price
  • EVOK $2.70
  • OMH $1.48
  • Analyst Decision
  • EVOK
  • OMH Hold
  • Analyst Count
  • EVOK 0
  • OMH 1
  • Target Price
  • EVOK N/A
  • OMH N/A
  • AVG Volume (30 Days)
  • EVOK 19.3K
  • OMH 5.5M
  • Earning Date
  • EVOK 08-12-2025
  • OMH 07-11-2025
  • Dividend Yield
  • EVOK N/A
  • OMH N/A
  • EPS Growth
  • EVOK N/A
  • OMH N/A
  • EPS
  • EVOK N/A
  • OMH N/A
  • Revenue
  • EVOK $11,594,083.00
  • OMH $7,976,578.00
  • Revenue This Year
  • EVOK $57.82
  • OMH $28.40
  • Revenue Next Year
  • EVOK $59.12
  • OMH $23.07
  • P/E Ratio
  • EVOK N/A
  • OMH N/A
  • Revenue Growth
  • EVOK 89.89
  • OMH 117.53
  • 52 Week Low
  • EVOK $1.94
  • OMH $0.59
  • 52 Week High
  • EVOK $12.32
  • OMH $6.20
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 43.42
  • OMH 46.07
  • Support Level
  • EVOK $2.50
  • OMH $1.32
  • Resistance Level
  • EVOK $2.84
  • OMH $1.58
  • Average True Range (ATR)
  • EVOK 0.20
  • OMH 0.12
  • MACD
  • EVOK -0.01
  • OMH 0.02
  • Stochastic Oscillator
  • EVOK 47.45
  • OMH 43.98

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: